Navigation Links
ViroPharma Initiates Phase 2 Study of VP 20621 for Prevention of Recurrence of Clostridium difficile Infection (CDI)
Date:5/19/2011

EXTON, Pa., May 19, 2011 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced initiation of a Phase 2 dose-ranging clinical study to evaluate the safety, tolerability, and efficacy of VP 20621 for prevention of recurrence of Clostridium difficile infection (CDI) in adults previously treated for CDI.

The objectives of this randomized, double-blind, placebo-controlled, dose ranging study are to evaluate the safety and tolerability of VP 20621 dosed orally for up to 14 days in adults previously treated for CDI; characterize the frequency and duration of stool colonization with VP 20621 strain of C. difficile; evaluate the efficacy of VP 20621 for prevention of recurrence of CDI; and select a dose regimen of VP 20621 to be used in future studies.  Eligible subjects will have been diagnosed with CDI and treated with metronidazole or oral vancomycin.  Subjects will be randomized into four different therapy groups, with study drug administered once daily after completion of CDI antibiotic treatment and continuing for up to 14 days.  Each subject will be followed for a total of 6 months.  The study will enroll at least 240 subjects, and will be conducted in North America and Europe.  

"Recurrence of CDI represents a therapeutic challenge with substantial associated morbidity, mortality and compromised quality of life, often requiring prolonged and repeated treatment courses," commented Colin Broom, M.D., ViroPharma's chief scientific officer.  "There are no immediate solutions on the horizon for prevention of recurrent CDI following antibiotic treatment.  However, based on the Phase 1 data with VP 20621, we are encouraged that this novel approach may one day fill this unmet clinical need."

About VP 20621

Antibiotics including those used to treat acute C. difficile infection (CDI) dis
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. ViroPharma to Present at the Natixis Bleichroeder Conference
3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma Announces Discontinuation of HCV-796 Development
6. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
7. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
8. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
9. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
10. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
11. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... 2014 - New Solution That ... JIN Co., Ltd. will launch JINS MEME "ACADEMIC ... 500,000 yen or $5,000 (without tax /including two pairs of ... is a dedicated solution of "JINS MEME" to academic researchers, ... data* generated by electrooculography and six-axis sensors without API. (*Physiological ...
(Date:11/26/2014)... -- Perrigo Company plc ("Perrigo") (NYSE: PRGO ; ... Products®," today announced the closing of Perrigo,s previously announced ... ordinary shares at a public offering price of $152.00 ... to purchase up to an additional 888,157 ordinary shares ... as representatives of the several underwriters. ...
(Date:11/26/2014)... 26, 2014   Regulus Therapeutics Inc . (NASDAQ: ... discovery and development of innovative medicines targeting microRNAs, today ... and CEO of Regulus, will present a company overview ... Conference at the New York Palace Hotel on Wednesday, ... will be webcast at the time of the presentation ...
Breaking Medicine Technology:JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 2JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 3Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 2Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 3Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 4Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 2Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 3
(Date:11/27/2014)... 27, 2014 Allowing children to help with ... school, helps give children responsibility, ownership, boosts self-esteem, and above ... , Now, the real question is, how do you encourage ... According to a study published by Child Development Journal, there ... dramatic effect on a child’s willingness to lend a hand. ...
(Date:11/27/2014)... "The uglier, the better," says Dr. Kirk Kimmerling. "Every ... as we enjoy the ugly sweater contest." Last year's ... " It was a sight to see. She glued ... the Christmas balls were faces of the staff with Dr. ... this year, it's simple to get in on the fun. ...
(Date:11/27/2014)... New Delhi, India (PRWEB) November 27, 2014 ... internet marketing company, has announced online reputation management ... after doing a comprehensive study about the world of ... Google, Bing, and Yahoo. , Ethane Web Technologies ... project. Instead, it first analyzes the project to reach ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 Ethane Web Technologies, ... it will provide a 10% Christmas discount on PPC service. ... December. The discount offer will begin on 1 December 2014 ... , About this offer, a PPC professional working at Ethane ... especially for small businesses, as this big discount would make ...
(Date:11/27/2014)... CA, (PRWEB) November 26, 2014 ... browser-based presentation platform, focused on increasing audience engagement ... Britannic Technologies. Lintelus’ software platform includes a multitude ... and presenter in a collaborative, interactive multi-screen environment. ... and the presentation in real time on their ...
Breaking Medicine News(10 mins):Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 3Health News:Ethane Web Technologies Announces Online Reputation Management Service 2Health News:Ethane Web Technologies Announces 10% Christmas Discount on PPC Service 2Health News:Lintelus Showcases its Feature-Rich Presentation Technology Solution at Convergence Summit’s Annual Event in London 2
... Lahore have arrested four doctors engaged in the illegally removing ... were made Friday night after police apprehended three middlemen and ... heavily guarded house in the city, Lahore police chief Aftab ... former patient then raided two private hospitals where the four ...
... services have been paralysed in a Bihar district as hundreds of ... police in rescuing two abducted school students who are close ... about 125 km from the state capital, went on a two-day ... Saurav, 12 and Gaurav, 12. Both the boys are student of ...
... case of H5N1 infection known as bird flu in a ... by his surname, Cheng, and said he was under treatment ... it did not specify his unit or say which region ... affairs. ,Cheng developed symptoms of fever, coughing and ...
... identify the places most at risk of devastating earthquakes. ... zones' that can spawn giant quakes, researchers attending a ... Society and several Latin American geophysical associations, claimed that ... a locked zone to the west of Seattle. ...
... Center (BMC) and Boston University School of Public Health ... immunodeficiency virus (HIV), who also have alcohol problems, ... virus (HCV). These findings appear in the June issue ... HIV and HCV is a significant medical and public ...
... cancer is an elevated rate of increase in prostate specific ... study found that a pre-treatment rate of PSA increase, called ... with a high risk of death from prostate cancer. Elevated ... other single high-risk indicator, such as a biopsy Gleason score ...
Cached Medicine News:Health News:Persons With HIV and Alcohol Problems Co-infected With Hepatitis C 2Health News:High Pretreatment PSA Velocity Predicts Worse Outcome 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: